Yaşar, S.; Kadıoğlu, A.; Akyildiz, A.; Sever, N.; Büyükbayram, M.E.; Bilici, M.; Karaman, E.; Uzun, M.; Bardakcı, M.; Koseoglu, C.;
et al. “Pre-Treatment“ and “Post-Treatment” Systemic Inflammatory Markers: Is There Any Prognostic Role for Metastatic Cervical Cancer on Bevacizumab Containing Treatment? Medicina 2025, 61, 1100.
https://doi.org/10.3390/medicina61061100
AMA Style
Yaşar S, Kadıoğlu A, Akyildiz A, Sever N, Büyükbayram ME, Bilici M, Karaman E, Uzun M, Bardakcı M, Koseoglu C,
et al. “Pre-Treatment“ and “Post-Treatment” Systemic Inflammatory Markers: Is There Any Prognostic Role for Metastatic Cervical Cancer on Bevacizumab Containing Treatment? Medicina. 2025; 61(6):1100.
https://doi.org/10.3390/medicina61061100
Chicago/Turabian Style
Yaşar, Serkan, Ahmet Kadıoğlu, Arif Akyildiz, Nadiye Sever, Mehmet Emin Büyükbayram, Mehmet Bilici, Elanur Karaman, Mehmet Uzun, Murat Bardakcı, Caglar Koseoglu,
and et al. 2025. "“Pre-Treatment“ and “Post-Treatment” Systemic Inflammatory Markers: Is There Any Prognostic Role for Metastatic Cervical Cancer on Bevacizumab Containing Treatment?" Medicina 61, no. 6: 1100.
https://doi.org/10.3390/medicina61061100
APA Style
Yaşar, S., Kadıoğlu, A., Akyildiz, A., Sever, N., Büyükbayram, M. E., Bilici, M., Karaman, E., Uzun, M., Bardakcı, M., Koseoglu, C., Bilgetekin, I., İçli, M. C., Türkel, A., Arık, Z., Sarı, M., Yavuzsen, T., Sendur, M. A. N., Erturk, İ., & Dogan, M.
(2025). “Pre-Treatment“ and “Post-Treatment” Systemic Inflammatory Markers: Is There Any Prognostic Role for Metastatic Cervical Cancer on Bevacizumab Containing Treatment? Medicina, 61(6), 1100.
https://doi.org/10.3390/medicina61061100
